Financial Performance - For the three months ended September 30, 2022, the company reported a net income of $521,774, driven by interest income of $1,132,777 from marketable securities held in the Trust Account[133]. - For the nine months ended September 30, 2022, the company achieved a net income of $5,560,298, with interest income of $1,514,086 and a gain in fair value of derivative warrant liabilities of $6,853,280[135]. Initial Public Offering - The company completed its Initial Public Offering on May 18, 2021, raising gross proceeds of $230,000,000 from the sale of 23,000,000 units at $10.00 per unit[137]. - The company incurred transaction costs of $13,107,291 related to the Initial Public Offering, including $4,600,000 in underwriting fees[138]. Financial Position - As of September 30, 2022, the company had cash and U.S. treasury securities in the Trust Account totaling $231,336,755, an increase from $230,040,937 as of December 31, 2021[140]. - The company had a working capital deficit of approximately $2.9 million as of September 30, 2022, raising concerns about its ability to continue as a going concern[145][146]. - The company has no long-term debt or capital lease obligations, only incurring a monthly fee of $10,000 for administrative services[148]. Business Combination - The company plans to use substantially all funds in the Trust Account to complete its Initial Business Combination and may withdraw interest to pay taxes[140]. - The company has less than 12 months to complete a Business Combination, with a deadline of May 18, 2023[144]. - There is no current commitment from any financing source to provide additional capital, which may impact the company's ability to execute its plans[145]. Internal Controls - The company's disclosure controls and procedures were effective as of September 30, 2022[155]. - No changes in internal control over financial reporting occurred during the fiscal quarter ended September 30, 2022, that materially affected internal controls[157].

FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40402 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OSIRIS ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) Delaware 85-3636928 (State or other ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40402 OSIRIS ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 85-3636928 | | --- | - ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40402 Osiris Acquisition Corp. (Exact name of Registrant as specified in its Charter) (State or other jurisdiction of ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40402 OSIRIS ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) | Delaware | | --- | (State or ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40402 OSIRIS ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) Delaware 85-3636928 (State or other ...